clinical trial · NCT04100135
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
W.L.Gore & Associates·N/A·terminated·n = 7
MigrainePatent Foramen OvalePFO - Patent Foramen OvaleActual device PFO closureThienopyridine (clopidogrel or prasugrel)Sham device PFO closure
brief summary
Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief
started
Feb 5, 2021
primary completion
Aug 15, 2024
completion
Aug 15, 2024
last updated
Dec 18, 2024
official title
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study: A Study to Evaluate the Safety and Efficacy of Transcatheter Closure of Patent Foramen Ovale for Relief of Migraine Headaches
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol